Current position:Home >Product >
(2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea
(2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea(175212-04-1)
- Name: (2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea
- Synonyms:
- Molecular Formula:C16H19FN2O4
- Molecular Weight:
- CAS Registry Number:175212-04-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.175212-04-1 CMI-977
Assay:98% Appearance:Powder Package:inquiry Storage:Store in a cool and dry place and at 0 - 4 掳C for short term (days to weeks) or -20 掳C for long term (months to years). Transportation:inquiry Application:CMI-977, an oxolan compound, has been found to be a 5-Lipoxygenases inhibitor and was once studied as an antiasthmatic agent.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 175210-49-8/6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, octahydro-10-oxo-9-[(1-oxo-3-phenylpropyl)amino]-, (1S,9S)-
- 175211-07-1/Benzoic acid, 2,6-dichloro-, (3S)-5-(1,1-dimethylethoxy)-2,5-dioxo-3-[[[2-oxo-3-[(1-oxo-3-phenylprop yl)amino]-6-(phenylmethyl)-1(2H)-pyridinyl]acetyl]amino]pentyl ester
- 175211-11-7/L-Alaninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-1-(2-benzoxazolylcarbonyl)- 3-(1,1-dimethylethoxy)-3-oxopropyl]-
- 175211-12-8/Benzoxazole, 7-methoxy-
- 175211-21-9/Pentanoic acid, 5-hydroxy-4-oxo-3-[[(2-propenyloxy)carbonyl]amino]-, 1,1-dimethylethyl ester, (3S)-
- 175211-23-1/L-Alaninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-3-[(2,6-dichlorophenyl)meth oxy]-1-[2-(1,1-dimethylethoxy)-2-oxoethyl]-2-oxopropyl]-
- 175211-28-6/Pentanoic acid, 5-[(2-chlorophenyl)methoxy]-4-oxo-3-[[(2-propenyloxy)carbonyl]amino]-, 1,1-dimethylethyl ester, (3S)-
- 175211-37-7/L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[(2-nitrophenyl)amino]-
- 175211-38-8/L-Alanine, 3-[(2-aminophenyl)amino]-N-[(1,1-dimethylethoxy)carbonyl]-
- 175211-39-9/Carbamic acid, [(3S)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]-, 1,1-dimethylethyl ester
- 175211-41-3/1H-1,5-Benzodiazepine-1-acetic acid, 2,3,4,5-tetrahydro-2-oxo-3-[(1-oxo-3-phenylpropyl)amino]-, methyl ester, (3S)-
- 175211-42-4/1H-1,5-Benzodiazepine-1-acetic acid, 2,3,4,5-tetrahydro-2-oxo-3-[(1-oxo-3-phenylpropyl)amino]-, (3S)-
- 175211-61-7/Pentanoic acid, 5-[[(2-chlorophenyl)methyl]thio]-4-oxo-3-[[[2-oxo-3-[(1-oxo-3-phenylprop yl)amino]-6-(phenylmethyl)-1(2H)-pyridinyl]acetyl]amino]-, 1,1-dimethylethyl ester, (3S)-
- 175211-64-0/Carbamic acid, (6-butyl-1,2-dihydro-2-oxo-3-pyridinyl)-, phenylmethyl ester
- 175211-65-1/Carbamic acid, [1,2-dihydro-2-oxo-6-(phenylmethyl)-3-pyridinyl]-, 2-phenylethyl ester
- 175211-67-3/Butanoic acid, 3-amino-4-[(aminocarbonyl)hydrazono]-, 1,1-dimethylethyl ester
- 175211-71-9/Oxazole, 5-(2,6-dichlorophenyl)-
- 175211-73-1/Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-(2-oxoethyl)-Methyl ester
- 17521-18-5/4-Thiazolidinone, 3-[[(3-nitrophenyl)methylene]amino]-2-thioxo-
- 175212-04-1/(2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea
- 175215-01-7/1H-1,2,4-Triazolium, 4-amino-1-[[4-(3,4-dimethoxyphenyl)-3-(ethoxycarbonyl)-6,7-dimethoxy- 2-quinolinyl]methyl]-, bromide
- 175215-24-4/[1,2,4]Triazolo[1,5-b]pyridazine, 6-chloro-7-(1-methylethyl)-
- 175220-70-9/Nitrous acid, 1,7-heptanediyl ester
- 175220-71-0/Nitrous acid, 3-chloro-2,2-dimethylpropyl ester
- 175220-72-1/Nitrous acid, 2-methyl-1,3-propanediyl ester
- 175220-73-2/Nitrous acid, 2-methyl-2-propyl-1,3-propanediyl ester
- 175220-74-3/Nitrous acid, 1,3-dimethylbutyl ester
- 175220-75-4/Nitrous acid, 1,5-dimethylhexyl ester
- 175220-77-6/Nitrous acid, 3-hydroxy-2,2-bis(hydroxymethyl)propyl ester
- 175220-78-7/Nitrous acid, 2,2-bis(hydroxymethyl)-1,3-propanediyl ester